Tailin Biotech announced that Tailin Medical Engineering, a wholly-owned subsidiary of the company, recently obtained an invention patent. The patent name is “a high-precision automatic mixing and dispensing device for radiopharmaceuticals and its distribution method”. The authorization announcement date is August 4, 2026. The patent will not have a significant impact on the recent production and operation of the company and its subsidiaries, but it is beneficial to improve the intellectual property protection system and enhance core competitiveness.

Tailin Biotech announced that Tailin Medical Engineering, a wholly-owned subsidiary of the company, recently obtained an invention patent. The patent name is “a high-precision automatic mixing and dispensing device for radiopharmaceuticals and its distribution method”. The authorization announcement date is August 4, 2026. The patent will not have a significant impact on the recent production and operation of the company and its subsidiaries, but it is beneficial to improve the intellectual property protection system and enhance core competitiveness.